SkinMind GmbH
AI-enabled skin cancer self-diagnosis.
Skin cancer is the most common cancer. 1 out of 5 people will experience skin cancer in their life. Early detection allows to save almost all patients, but if it is detected late, therapy costs will be very high, and 1 out of 2 patients will die. Self-examination by patients can play a crucial role in early detection, but without a trustworthy tool, it is not easy and efficient. Patients need support for easy and quick self-check of skin lesions.
The founder Sepehr Beheshti with +6y of experience in data science, getting an MSc degree in AI from USI. Our solution is an AI system able to recognize types of skin lesions by analyzing skin image and patient data with the accuracy equivalent to a +10y experienced dermatologist. Our 1st Market size is CHF 1.3B in the EU and CHF 3.9B worldwide.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
SkinMind GmbH
AI-enabled skin cancer self-diagnosis.
Website:
www.SkinMind.ch
Headquarter:
Viganello
Foundation Date:
July 2024
Technology:
- Medtech
Sectors:
- Cancer
- Diagnostics
- Machine Learning / AI
- Medtech
Support received
